CURIS, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CURIS, INC. treasury stock, shares, acquired for the quarter ending 2018-03-31 was 244.57K shares.
- CURIS, INC. treasury stock, shares, acquired for fiscal 2017 was 244.57K shares.
- CURIS, INC. treasury stock, shares, acquired for fiscal 2012 was 0.00 shares.
- CURIS, INC. treasury stock, shares, acquired for fiscal 2002 was 209.54K shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2018-03-31 | 244.57K shares 10-K · filed 2019-03-26 | |
| 2017-12-31 | 244.57K shares 10-K · filed 2019-03-26 | |
| 2012-12-31 | 0.00 shares 10-K · filed 2013-03-13 | |
| 2002-12-31 | 209.54K shares 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |